Oxford BioDynamics (LON:OBD) Trading Down 6.7% – Here’s What Happened

Posted by Lisa Durand on Jan 4th, 2025

Oxford BioDynamics Plc (LON:OBD – Get Free Report) fell 6.7% on Thursday . The stock traded as low as GBX 1.30 ($0.02) and last traded at GBX 1.40 ($0.02). 677,375 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 1,873,925 shares. The stock had previously closed at GBX 1.50 ($0.02).

Oxford BioDynamics Stock Performance

The firm has a fifty day moving average of GBX 1.27 and a 200-day moving average of GBX 4.10. The company has a quick ratio of 2.80, a current ratio of 0.68 and a debt-to-equity ratio of 370.22. The stock has a market capitalization of £3.74 million, a price-to-earnings ratio of -20.00 and a beta of 0.42.

Insider Activity

In related news, insider David Holbrook acquired 49,653 shares of the business’s stock in a transaction that occurred on Monday, October 28th. The stock was purchased at an average cost of GBX 1 ($0.01) per share, for a total transaction of £496.53 ($616.81). Company insiders own 16.78% of the company’s stock.

Oxford BioDynamics Company Profile

(Get Free Report)

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.